- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2316-7874
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Lipid-lowering properties of protein-rich mucuna product ; volume:41 ; number:1 ; day:25 ; month:5 ; year:2016 ; pages:1-10 ; date:12.2016
Nutrire ; 41, Heft 1 (25.5.2016), 1-10, 12.2016
- Creator
-
Ngatchic, Josiane Therese Metsagang
- Contributor
-
Njintang, NicolasYanou
Bernard, Clemence
Oben, Julius
Mbofung, Carl Moses
SpringerLink (Online service)
- DOI
-
10.1186/s41110-016-0003-0
- URN
-
urn:nbn:de:1111-2016062813991
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ngatchic, Josiane Therese Metsagang
- Njintang, NicolasYanou
- Bernard, Clemence
- Oben, Julius
- Mbofung, Carl Moses
- SpringerLink (Online service)
Other Objects (12)
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Nicotinic acid: a lipid-lowering agent with unrealized potential
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Initial non-adherence to lipid-lowering medication: a systematic literature review
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
In vitro study on antioxidant and lipid-lowering activities of tobacco polysaccharides
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Nicotinic acid: a lipid-lowering agent with unrealized potential
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Initial non-adherence to lipid-lowering medication: a systematic literature review
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
In vitro study on antioxidant and lipid-lowering activities of tobacco polysaccharides
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Nicotinic acid: a lipid-lowering agent with unrealized potential
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Initial non-adherence to lipid-lowering medication: a systematic literature review
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
In vitro study on antioxidant and lipid-lowering activities of tobacco polysaccharides